Ex-CME chief Gill joins US medical futures exchange
Phupinder Gill, a former chief executive of CME Group, has taken a role at a new medical derivatives exchange which applied for US approval on Tuesday
Existing Subscriber?
If you are an existing subscriber please sign in to read this article in full.
Sign InSign up for a free trial
Take a complimentary trial to the FOW Marketing Intelligence Platform and gain access to a wealth of news, analysis and data across the Asset Management, Securities Finance, Custody, Fund Services and Derivatives markets.
Sign up for a free trial
